Dela Fuente, Arlene C.
HRN: 04-24-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
CEFUROXIME 500MG (TAB)
06/16/2022
06/22/2022
ORAL
500mg
BID
Complete Abortion
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes